Alicia J. Schade
- Hematology top 1%
- Immunology top 5%
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Larry V. McIntireJing-fei DongKazuo FujikawaLeticia NolascoAubrey BernardoCorie N. ShrimptonJoel L. MoakeJosé A. López
- Topics
- Platelet Disorders and Treatments (8 papers)Blood groups and transfusion (7 papers)Heparin-Induced Thrombocytopenia and Thrombosis (2 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryThe Journal of Experimental Medicine
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Alicia J. Schade
10 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Hematology 955
- Immunology 517
- Molecular Biology 234
- Cardiology and Cardiovascular Medicine 193
- Pulmonary and Respiratory Medicine 173
Countries citing papers authored by Alicia J. Schade
This map shows the geographic impact of Alicia J. Schade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia J. Schade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia J. Schade more than expected).
Fields of papers citing papers by Alicia J. Schade
This network shows the impact of papers produced by Alicia J. Schade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia J. Schade. The network helps show where Alicia J. Schade may publish in the future.
Co-authorship network of co-authors of Alicia J. Schade
This figure shows the co-authorship network connecting the top 25 collaborators of Alicia J. Schade. A scholar is included among the top collaborators of Alicia J. Schade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia J. Schade. Alicia J. Schade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditionsbreakdown → | 666 |
| 3 | 117 | |
| 4 | 38 | |
| 5 | 44 | |
| 6 | Mutation in the leucine-rich repeat of platelet glycoprotein Ib alpha results in defects in its interaction with immobilized von Willebrand factor under flow. | 0 |
| 7 | 12 | |
| 8 | 108 | |
| 9 | 257 | |
| 10 | 11 | |
| 11 | 119 |
About Alicia J. Schade
Alicia J. Schade is a scholar working on Hematology, Immunology and Allergy and Electrochemistry, having authored 11 papers that have together received 1.4k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (8 papers), Blood groups and transfusion (7 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). The work is most often cited by research in Hematology (955 citations), Immunology (517 citations) and Immunology and Allergy (146 citations). Alicia J. Schade has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Larry V. McIntire, Jing-fei Dong, Kazuo Fujikawa, Leticia Nolasco, Aubrey Bernardo, Corie N. Shrimpton, Joel L. Moake, José A. López, Michael C. Berndt and Gabriel M. Romo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.